This page lists all pharmaceutical reports related to the field of Metabolic & Hormonal Disorders. The reports include market research reports and pipeline analyses.
- The World Market for Prescription Orthopedic Drugs
- Womens Health: Worldwide Prescription Drug Markets
- Advances in Ophthalmology: Markets in the Treatment of Eye Disorders and Corrective Vision
- The Protein Therapeutics Market: The Science and Business of a Growing Sector
- Critical Care Pharmaceutical Markets: A Strategic Analysis
- Diabetes and Diabetic Complications: Major World Markets
- Diabetes, Metabolic Syndrome and Cardiovascular Disease
- Women's Health: Diagnostic Tests
- Blood Glucose Testing and Diabetes Management
- The Global Endocrine Pharmaceutical Market 2005
- The World Diabetes Market, 2005-2011
- Cannabinoid Market Forecasts & Analysis to 2012
- Pipeline Insight: Dyslipidemia - Pipeline agents unlikely to rejuvenate the market
- Pipeline Insight: Osteoporosis - Intermittent dosing drives market growth
- Early Toxicology: Markets and Approaches
- Atherosclerosis - HDL, ApoA-I, Carotid MRI and 64-slice CT offer opportunities
- Obesity - Lack of Reimbursement Limits Market Potential
- Hormonal Contraceptives - New directions in a competitive market
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Pipeline Insight: Insulins - Inhalable insulins unlikely to become blockbusters
- Antidiabetics - Patent expiries and cost containment initiatives balanced by pipeline products
- Non-insulin Antidiabetics - Type 2 diabetes unlikely to develop into a switch market
- Antidyslipidemics - The Generic Threat
- From Blockbuster to Nichebuster
- Monoclonal Antibodies 2007
- The Global Protein Therapeutics Market
- Biogenerics
- Metabolic Syndrome - Multiple definitions complicate treatment
- The Global Diabetes Market
- Drug Treatment in End-Stage Renal Disease
- Antidyslipidemics
- Inhalable Drug Delivery
- Therapeutic Vaccines
- Pipeline Insight: Osteoporosis
- Hypertension and Diabetic Kidney Disease - Prevalence, current treatment and future options
- Dyslipidemia - Statins Dominate Treatment Pathway
- Pipeline Insight: Antidyslipidemics
- Commercial Insight: Antidiabetics
- Commercial Insight: Antidyslipidemics
- HRT: Major Milestones - Current Perspectives on HRT and Menopause
- Monoclonal Antibodies: Financial and strategic analysis of the mAb market
- Osteoporosis - Risk management and reformulation offer best defense against generic onslaught
- Drug Discovery Tools for High-Content Analysis
- The Women’s Health Market Outlook to 2011
- Commercial Insight: Antidyslipidemics - The competitive cost-conscious antidyslipidemics market presents challenges
- TYPE 1 DIABETES - Therapy Area Pipeline Report
- DYSLIPIDEMIA - Therapy Area Pipeline Report
- HYPERLIPEMIA - Therapy Area Pipeline Report
- ATHEROSCLEROSIS and CORONARY ARTERY DISEASE - Therapy Area Pipeline Report
- HYPERCHOLESTEROLEMIA - Therapy Area Pipeline Report
- DIABETIC NEUROPATHY - Therapy Area Pipeline Report
- Infertility - Therapy Area Pipeline Report
- MENOPAUSAL SYMPTOMS - Therapy Area Pipeline Report
- Peripheral Neuropathy and Neuropathic Pain, 2008
- CONTRACEPTION - Therapy Area Pipeline Report
- Top Companies and Products in the RNA/DNA Therapy Products Market
- Anti-Obesity Treatments 2007-2012 - A blockbuster market
- Drug Delivery Technology: Revolutionizing Diabetes Treatment
- Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
- Commercial and Pipeline Insight: Infertility
- Biosimilars Series: Strategic issues - Potential remains uncertain
- Translational Medicine in Biopharmaceutical Research and Development
- The World Diabetes Market, 2006-2025
- Licensing Strategies - Current Pharmaceutical Licensing Trends
- Pediatric Drugs - the Worldwide Market
- Stakeholder Opinions: Endometriosis - Scientific clarity will unlock market potential
- Diabetic Nephropathy - Prevalence and Therapeutic Potential
- Landmark Anti-dyslipidemic Trials Update - How Low Can You Go?
- OTC Statins - The UK Experience
- Pipeline Insight: Diabetes Drug Delivery and Diagnostics - Towards the Non-invasive Revolution
- Commercial Perspectives: Anti-dyslipidemics - A tale of two launches
- Pipeline Insight: Osteoporosis - Intermittent Dosing and Multiple Indications Drive Market Growth
- Stakeholder Insight: Dyslipidemia - Titration versus Combination Therapy
- Commercial and Pipeline Perspectives: Obesity - Super-sized Epidemic
- Stakeholder Insight: Metabolic Syndrome - Ticking Time Bomb
- Stakeholder Insight: Insulin Use in Type 2 Diabetes - From Last Resort to Early Intervention
- Pipeline Insight: Non-insulin Antidiabetics - Three New Classes Compete for Market Control
- Commercial Insight: Osteoporosis and HRT - Novel Osteoporosis Drugs Counter Generic Threat
- Stakeholder Insight: Diabetic Neuropathic Pain - Market Success is Not Limited to Pregabalin
- Stakeholder Insight: Metabolic Syndrome - Multiple definitions complicate treatment
- The Lifestyle Drugs Outlook to 2008: Unlocking new value in well-being
- The Women's Health Outlook to 2008: Market and pipeline analysis of major female disorders
- Commercial Opportunities from an Aging Population: Epidemiology, market and pipeline analysis across seven major indications
- Women's Health: Worldwide Prescription Drug Markets - 3rd Edition
- Men's Health: The World Market for Current and Emerging Drug Therapies
- Type II Diabetes: The 45+ Market in the United States for Drugs and Diagnostics
- Inhaled Insulin: A Market Briefing
- Gene Expression Profiling Markets
- The Pharmaceutical Company Outlook to 2012: Strategic Analysis of Sales Outlook for Big Pharma
- Lifestyle Drugs Market Outlook: Key Indications, Epidemiology, and Emergent Drugs
- How to Conduct Clinical Trials in China
- Stakeholder Insight: Diabetes
- Launching Combination Products: Brand extension and franchise development strategies
- PAD Interventional Market Analysis: Angioplasty and Atherectomy
- Acute Limb Ischemia - A market of multiple therapies and multiple procedures
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
- Biogenerics - The World Market: Biosimilars and Biologics at a Crossroads
- The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
- The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players
- HRT for Menopausal Symptoms: Commercial Opportunities and Pipeline Insight
